Ocugen Inc. stock rises Friday, outperforms market


Shares of Ocugen Inc.
OCGN,

surged 12.98% to $11.84 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index
SPX,

rising 0.19% to 4,605.38 and the Dow Jones Industrial Average
DJIA,

rising 0.25% to 35,819.56. This was the stock’s third consecutive day of gains. Ocugen Inc. closed $6.93 below its 52-week high ($18.77), which the company achieved on February 8th.

The stock outperformed some of its competitors Friday, as Adverum Biotechnologies Inc.
ADVM,

rose 8.10% to $2.27, Ocular Therapeutix Inc.
OCUL,

fell 3.07% to $6.64, and Kodiak Sciences Inc.
KOD,

fell 0.14% to $117.09. Trading volume (51.7 M) eclipsed its 50-day average volume of 22.4 M.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.



Read More: Ocugen Inc. stock rises Friday, outperforms market

article_normalBiopharmaceuticalsBiotechnologyBusinessBusiness/Consumer ServicesC&E Exclusion FilterC&E Industry News Filterclinicalconsumer servicesContent TypescorporateCorporate/Industrial Newsdiagnostic servicesdisruptionsFactiva FiltersFinancial PerformanceFridayHealthcareHealthcare Support ServicesHealthcare/Life Sciencesindustrial newslife sciencesmarketMedicalmedical equipmentMedical Equipment/SuppliesMedical Research ServicesMedical/Clinical/Diagnostic ServicesmedicationsOCGNOcugenoutperformsPharmaceuticalsProteomicsrisesScientific Research Servicesshare price movementShare Price Movement/Disruptionsspecialized drugsSpecialized Drugs/Medicationsstocksupplies
Comments (0)
Add Comment